Thus, to establish if KISS1R expression can influence sensitivity to kisspeptin in prostate cancer, we performed fluorescence based calcium mobilization assays in control (shSCX) and shRb LNCaP and 22Rv1 cells after normoxia or hypoxia treatments. The gene discussed is KISS1; the disease is prostate cancer.